November 28, 2012
Article
Editorial Advisory Board
November 21, 2012
CME Reviews
Diabetes
November 20, 2012
Editor's Page
Letter from the Publisher
What Your Patients Are Reading
News & Trends
Meeting Report
Marc Rothenberg, MD, PhD: EoE Receives First FDA Approval with Dupilumab
Systematic Review Suggests Oral JAK Inhibitors Effective in AD
Study Identifies 24 Adverse Events Associated with Secukinumab Treatment